Estrogenic effects of ginsenoside Rg1 in endometrial cells in vitro were not observed in immature CD-1 mice or ovariectomized mice model

Menopause

Volumn 19, Issue 9, 2012, Pages 1052-1061

  Chen, Wen Fang ^a,b   Gao, Quan Gui ^a   Dai, Zhi Jie ^c   Kung, Annie Wai Chee ^c   Guo, De An ^d   Wong, Man Sau ^a,e  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^e State Key Laboratory of Chinese Medicine and Molecular Pharmacology (Incubation)   (China)

Author keywords

C57BL 6J mice; CD 1 mice; Estrogen receptor; Ginsenoside Rg1; Ishikawa cells; MC3T3 E1 cells

Indexed keywords

ALKALINE PHOSPHATASE; ESTROGEN RECEPTOR ALPHA; GINSENOSIDE RG 1; LUCIFERASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN BCL 2;

ANIMAL MODEL; ARTICLE; BONE DENSITY; C57BL 6 MOUSE; CELL STRAIN; CONTROLLED STUDY; ENDOMETRIUM CELL; ENZYME ACTIVITY; ESTROGEN ACTIVITY; ESTROGEN RESPONSIVE ELEMENT; ESTROGEN THERAPY; FEMALE; FEMUR; GENE EXPRESSION; IN VITRO STUDY; LONG TERM CARE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TIBIA; UTERUS; UTERUS WEIGHT;

ANIMALS; BONE DENSITY; CELL LINE; DRUGS, CHINESE HERBAL; ENDOMETRIUM; ESTROGENS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION; GENES, BCL-2; GINSENOSIDES; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; ORGAN SIZE; OSTEOBLASTS; OVARIECTOMY; PHOSPHORYLATION; RECEPTORS, ESTROGEN; RNA, MESSENGER; UTERUS;

EID: 84865708036     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e318250361c     Document Type: Article

References (44)

1. Nelson HD, Humphrey LL, Nygren P, Teutsch PM, Allan JD. Postmenopausal hormone replacement therapy: scientific review. JAMA 2002;288: 872-881.
2. Tang MX, Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996;348:429-432.
3. Davison S, Davis SR. Hormone replacement therapy: current controversies. Clin Endocinol 2003;58:249-261.
4. Cornwell T, Cohick W, Raskin I. Dietary phytoestrogens and health. Phytochemistry 2004;65:995-1016.
5. Osborne CK, Zhao H, Fuqua SA. Selective estrogen receptor modulators: structure, function, and clinical use. J Clin Oncol 2000;18:3172-3186.
6. Lee YJ, Jin YR, Lim WC, et al. Ginsenoside-Rb1 acts as a weak phytoestrogen in MCF-7 human breast cancer cells. Arch Pharm Res 2003;26: 58-63.
7. Seidlova-Wuttke D, Hesse O, Jarry H, et al. Evidence for selective estrogen receptor modulator activity in a black cohosh (Cimicifuga racemosa) extract: comparison with estradiol-17A. Eur J Endocrinol 2003; 149:351-362.
8. Kim SY, Seo SK, Choi YM, et al. Effects of red ginseng supplementation on menopausal symptoms and cardiovascular risk factors in postmenopausal women: a double-blind randomized controlled trial. Menopause 2012;19:461-466.
9. Geller SE, Studee L. Botanical and dietary supplements for mood and anxiety in menopausal women. Menopause 2007;14:541-549.
10. Yakoot M, Salem A, Omar AM. Effectiveness of a herbal formula in women with menopausal syndrome. Forsch Komplementmed 2011;18: 264-268.
11. Qi LW, Wang CZ, Yuan CS. American ginseng: potential structurefunction relationship in cancer chemoprevention. Biochem Pharmacol 2010;80:947-954.
12. Christensen LP. Ginsenoside chemistry, biosynthesis, analysis, and potential effects. Adv Food Nutr Res 2009;55:1-99.
13. Liu CX, Xiao PG. Recent advances on ginseng research in China. J Ethnopharmacol 1992;36:27-38.
14. Chan RY, Chen WF, Dong A, Guo D, Wong MS. Estrogen-like activity of ginsenoside Rg1 derived from Panax nogoginseng. J Clin Endocrinol Metab 2002;87:3691-3695.
15. Lau WS, Chan RY, Guo GA, Wong MS. Ginsenoside Rg1 exerts estrogen-like activities via ligand-independent activation of ER pathway. J Steroid Biochem Mol Biol 2008;108:64-71.
16. Lau WS, Chen WF, Chan RY, Guo DA, Wong MS. Mitogen-activated protein kinase (MAPK) pathway mediates the oestrogen-like activities of ginsenoside Rg1 in human breast cancer (MCF-7) cells. Br J Pharmacol 2009;156:1136-1146.
17. Chen WF, Lau WS, Cheung PY, Guo DA, Wong MS. Activation of insulin-like growth factor I receptor-mediated pathway by ginsenoside Rg1. Br J Pharmacol 2006;147:542-551.
18. Xu L, Chen WF, Wong MS. Ginsenoside Rg1 protects dopaminergic neurons in a rat model of Parkinson's disease through the IGF-I receptor signaling pathway. Br J Pharmacol 2009;158:738-748.
19. Gao QG, Chen WF, Xie JX, Wong MS. Ginsenoside Rg1 protects against 6-OHDA-induced neurotoxicity in neuroblastoma SK-N-SH cells via IGF-I receptor and estrogen receptor pathways. J Neurochem 2009;109: 1338-1347.
20. Chen WF, Wong MS. Genistein enhances insulin-like growth factor signaling pathway in human breast cancer (MCF-7) cells. J Clin Endocrinol Metab 2004;89:2351-2359.
21. Geiser AG, Hummel CW, Draper MW, et al. A new selective estrogen receptor modulator with potent uterine antagonist activity, agonist activity in bone, and minimal ovarian stimulation. Endocrinology 2005;146: 4524-4535.
22. Wober J, WeiQwange I, Vollmer G. Stimulation of alkaline phosphatase activity in Ishikawa cells induced by various phytoestrogens and synthetic estrogens. J Steroid Biochem Mol Biol 2003;83:227-233.
23. Chen X, Garner SC, Quarles LD, Anderson JJ. Effects of genistein on expression of bone markers during MC3T3-E1 osteoblastic cell differentiation. J Nutr Biochem 2003;14:342-349.
24. Kanno S, Hirano S, Kayama F. Effects of phytoestrogens and environmental estrogens on osteoblastic differentiation in MC3T3-E1 cells. Toxicology 2004;196:137-145.
25. Paech K, Webb P, Kuiper GG, et al. Differential ligand activation of estrogen receptors ER> and ERA at AP1 sites. Science 1997;277: 1508-1510.
26. Bhat KPL, Pezzuto JM. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells. Cancer Res 2001;61:6137-6144.
27. Kassan S, Mechanick JI, Gurpide E. Altered estrogen receptor system in estrogen-unresponsive human endometrial adenocarcinoma cells. J Steroid Biochem 1989;33:327-333.
28. Lomnitski L, Padilla-Banks E, Jefferson WN, Nyska A, Grossman S, Newbold RR. A natural antioxidant mixture from spinach does not have estrogenic or antiestrogenic activity in immature CD-1 mice. J Nutr 2003; 133:3584-3587.
29. Takahashi T, Eitzman B, Bossert NL, et al. Transforming growth factors A 1, A 2, and A 3 messenger RNA and protein expression in mouse uterus and vagina during estrogen-induced growth: a comparison to other estrogenregulated genes. Cell Growth Differ 1994;5:919-935.
30. An BS, Choi KC, Hong EJ, Jung YW, Manabe N, Jeung EB. Differential transcriptional and translational regulations of calbindin-D9k by steroid hormones and their receptors in the uterus of immature mice. J Reprod Dev 2004;50:445-453.
31. Weihua Z, Saji S, Makinen S, et al. Estrogen receptor (ER) A, a modulator of ER in the uterus. Proc Natl Acad Sci USA 2000;97:5936-5941.
32. Beri R, Kumar N, Savage T, Benalcazar L, Sundaram K. Estrogenic and progestational activity of 7-methyl-19-nortestosterone, a synthetic androgen. J Steroid Biochem Mol Biol 1998;67:275-283.
33. Patel R, Rosengren RJ. Acetaminophen elicits anti-estrogenic but not estrogenic responses in the immature mouse. Toxicol Lett 2001;122:89-96.
34. Waters KM, Safe S, Gaido KW. Differential gene expression in response to methoxychlor and estradiol through ER, ERA, and AR in reproductive tissues of female mice. Toxicol Sci 2001;63:47-56.
35. Frasor J, Barnett DH, Danes JM, Hess R, Parlow AF, Katzenellenbogen BS. Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) activity by ERA in the uterus. Endocrinology 2003; 144:3159-3166.
36. Li YQ, Xing XH, Wang H, et al. Dose-dependent effects of genistein on bone homeostasis in rats' mandibular subchondral bone. Acta Pharmacol Sin 2012;33:66-74.
37. Uchiyama S, Yamaguchi M. Genistein and zinc synergistically enhance gene expression and mineralization in osteoblastic MC3T3-E1 cells. Int J Mol Med 2007;19:213-220.
38. Catalano S, Mauro L, Marsico S, et al. Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor in MCF-7 cells. J Biol Chem 2004;279:19908-19915.
39. EI-Tanani MKK, Green CD. Two separate mechanisms for ligandindependent activation of the estrogen receptor. Mol Endocrinol 1997; 11:928-937.
40. Lu JM, Yao QZ, Chen CY. Ginseng compounds: an update on their molecular mechanisms and medical applications. Curr Vasc Pharmacol 2009;7:293-302.
41. Deng J, Lv XT, Wu Q, Huang XN. Ginsenoside Rg1 inhibits rat left ventricular hypertrophy induced by abdominal aorta coarctation: involvement of calcineurin andmitogen-activated protein kinase signalings. Eur J Pharmacol 2009;608:42-47.
42. Zhu D, Wu L, Li CR, et al. Ginsenoside Rg1 protects rat cardiomyocyte from hypoxia/reoxygenation oxidative injury via antioxidant and intracellular calcium homeostasis. J Cell Biochem 2009;108:117-124.
43. Shi YQ, Huang TW, Chen LM, et al. Ginsenoside Rg1 attenuates amyloid-A content, regulates PKA/CREB activity, and improves cognitive performance in SAMP8 mice. J Alzheimers Dis 2010;19:977-989.
44. Xu L, Liu LX, Chen WF. Effect and mechanism on dopamine contents of striatum in rat model of Parkinson's disease ginsenoside Rg1. Zhongguo Zhong Yao Za Zhi 2008;33:1856-1859.